Fibrolamellar Carcinoma Follow-up

Updated: Sep 17, 2015
  • Author: Michael A Choti, MD, MBA, FACS; Chief Editor: N Joseph Espat, MD, MS, FACS  more...
  • Print
Follow-up

Further Outpatient Care

 

Next:

Prognosis

Prognosis after surgical therapy is superior to that with any medical management alone.

Patients with unresectable metastatic fibrolamellar carcinoma have a median survival of 14 months. [79]

Previous